organization · Reporting owner

MITSUI & CO LTD

Disclosed activity across 4 companies

Tapewire entity: 76868
SEC CIK: 0000067099

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Atlas Lithium CorpATLX · Entity 1110	10% owner	April 04, 2024	April 11, 2024
Firefly Aerospace Inc.FLY · Entity 4140	10% owner	August 06, 2025	August 07, 2025
PENSKE AUTOMOTIVE GROUP, INC.PAG · Entity 1680	10% owner	March 27, 2018	March 27, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Atlas Lithium Corp

Report date April 04, 2024 · Filed April 11, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,871,250	Reported balance Holding disclosure · report date 2024-04-04 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 1,871,250

Firefly Aerospace Inc.

Report date August 06, 2025 · Filed August 07, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	5,033,120	Reported balance Holding disclosure · report date 2025-08-06 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 5,033,120 F1: The shares of common stock reported hereby give effect to the automatic conversion of the Issuer's preferred stock pursuant to the Issuer's Twelfth Amended and Restated Certificate of Incorporation. Such securities were held by the reporting person at the time the Issuer's common stock became registered pursuant to Section 12 of the Securities Exchange Act of 1934.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of common stock reported hereby give effect to the automatic conversion of the Issuer's preferred stock pursuant to the Issuer's Twelfth Amended and Restated Certificate of Incorporation. Such securities were held by the reporting person at the time the Issuer's common stock became registered pursuant to Section 12 of the Securities Exchange Act of 1934.

PENSKE AUTOMOTIVE GROUP, INC.

Report date March 27, 2018 · Filed March 27, 2018

Jointly reported with MITSUI & CO USA INC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	10,658,163	Reported balance After 2018-03-27 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2018-03-27 · Sale · Disposed 906,413 · Balance 10,658,163 F1: Shares sold pursuant to the Purchase Agreement, by and between the Reporting Persons and Penske Automotive Group, Inc., dated March 27, 2018.
Common StockSEC Table I · non-derivative	Direct	2,664,042	Reported balance After 2018-03-27 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2018-03-27 · Sale · Disposed 226,603 · Balance 2,664,042 F1: Shares sold pursuant to the Purchase Agreement, by and between the Reporting Persons and Penske Automotive Group, Inc., dated March 27, 2018. F2: These shares are owned of record and beneficially by Mitsui & Co. (U.S.A.), Inc., a wholly owned subsidiary of Mitsui & Co., Ltd.

Filing footnotes · ownership attribution and instrument terms

F1: Shares sold pursuant to the Purchase Agreement, by and between the Reporting Persons and Penske Automotive Group, Inc., dated March 27, 2018.

F2: These shares are owned of record and beneficially by Mitsui & Co. (U.S.A.), Inc., a wholly owned subsidiary of Mitsui & Co., Ltd.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Thorne Healthtech, Inc.

Report date October 16, 2023 · Filed October 17, 2023

Section 16 reporting ended · disclosed 2023-10-17. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2023-10-16 transaction · row 1 1 source row Row 1 · 2023-10-16 · Other · Disposed 15,674,235 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 27, 2023, by and among Thorne HealthTech, Inc. (the "Issuer"), Healthspan Buyer, LLC, and Healthspan Merger Sub, Inc. ("Purchaser"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer ("Company Common Stock") and thereafter merged with and into the Issuer (the "Merger") effective as of October 16, 2023 (the "Effective Time"). At the Effective Time, each outstanding share of Company Common Stock was cancelled and converted into the right to receive $10.20 in cash (the "Offer Price"), without interest and subject to applicable withholding taxes.
Class A Common Stock Warrant (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.12	Direct	0	Reported balance After 2023-10-16 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2023-10-16 · Other · Disposed 56,515 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each Class A Common Stock Warrant ("Company Warrant") held by the Reporting Person was automatically cancelled and converted into a right to receive an amount in cash, without interest, equal to the product of (A) the amount of the Offer Price (less the exercise price per share attributable to such Company Warrant) multiplied by (B) the total number of shares of Company Common Stock issuable upon exercise in full of such Company Warrant, subject to applicable withholding taxes.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 27, 2023, by and among Thorne HealthTech, Inc. (the "Issuer"), Healthspan Buyer, LLC, and Healthspan Merger Sub, Inc. ("Purchaser"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer ("Company Common Stock") and thereafter merged with and into the Issuer (the "Merger") effective as of October 16, 2023 (the "Effective Time"). At the Effective Time, each outstanding share of Company Common Stock was cancelled and converted into the right to receive $10.20 in cash (the "Offer Price"), without interest and subject to applicable withholding taxes.

F2: Pursuant to the Merger Agreement, at the Effective Time, each Class A Common Stock Warrant ("Company Warrant") held by the Reporting Person was automatically cancelled and converted into a right to receive an amount in cash, without interest, equal to the product of (A) the amount of the Offer Price (less the exercise price per share attributable to such Company Warrant) multiplied by (B) the total number of shares of Company Common Stock issuable upon exercise in full of such Company Warrant, subject to applicable withholding taxes.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 16, 2023 Filed Oct 17, 2023 20:15 UTC	Thorne Healthtech, Inc. THRN · Entity 108928	OtherClass A Common Stock Warrant (Right to buy) · Derivative	56,515	Not disclosed Strike: $5.12	Not disclosed	Disclosure SEC source: 0001209191-23-052958 · doc4.xml · derivative · entry 2 MITSUI & CO LTD · CIK 0000067099 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,515 shares Expires not disclosed F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each Class A Common Stock Warrant ("Company Warrant") held by the Reporting Person was automatically cancelled and converted into a right to receive an amount in cash, without interest, equal to the product of (A) the amount of the Offer Price (less the exercise price per share attributable to such Company Warrant) multiplied by (B) the total number of shares of Company Common Stock issuable upon exercise in full of such Company Warrant, subject to applicable withholding taxes. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each Class A Common Stock Warrant ("Company Warrant") held by the Reporting Person was automatically cancelled and converted into a right to receive an amount in cash, without interest, equal to the product of (A) the amount of the Offer Price (less the exercise price per share attributable to such Company Warrant) multiplied by (B) the total number of shares of Company Common Stock issuable upon exercise in full of such Company Warrant, subject to applicable withholding taxes. F2 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each Class A Common Stock Warrant ("Company Warrant") held by the Reporting Person was automatically cancelled and converted into a right to receive an amount in cash, without interest, equal to the product of (A) the amount of the Offer Price (less the exercise price per share attributable to such Company Warrant) multiplied by (B) the total number of shares of Company Common Stock issuable upon exercise in full of such Company Warrant, subject to applicable withholding taxes. Read SEC document
October 16, 2023 Filed Oct 17, 2023 20:15 UTC	Thorne Healthtech, Inc. THRN · Entity 108928	OtherCommon Stock	15,674,235	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-23-052958 · doc4.xml · nonDerivative · entry 1 MITSUI & CO LTD · CIK 0000067099 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 27, 2023, by and among Thorne HealthTech, Inc. (the "Issuer"), Healthspan Buyer, LLC, and Healthspan Merger Sub, Inc. ("Purchaser"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer ("Company Common Stock") and thereafter merged with and into the Issuer (the "Merger") effective as of October 16, 2023 (the "Effective Time"). At the Effective Time, each outstanding share of Company Common Stock was cancelled and converted into the right to receive $10.20 in cash (the "Offer Price"), without interest and subject to applicable withholding taxes. Read SEC document
September 27, 2021 Filed Sep 29, 2021 21:01 UTC	Thorne Healthtech, Inc. THRN · Entity 108928	ConversionSeries E Preferred Stock · Derivative	13,505,750	$0.00	$0.00	Disclosure SEC source: 0001209191-21-058073 · doc4.xml · derivative · entry 2 MITSUI & CO LTD · CIK 0000067099 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,505,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series E Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.exercise_date: The Series E Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. F1 · derivative.expiration_date: The Series E Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. Read SEC document
September 27, 2021 Filed Sep 29, 2021 21:01 UTC	Thorne Healthtech, Inc. THRN · Entity 108928	ConversionCommon Stock	13,505,750	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-058073 · doc4.xml · nonDerivative · entry 1 MITSUI & CO LTD · CIK 0000067099 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,674,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series E Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date. Read SEC document
March 27, 2018 Filed Mar 27, 2018 21:05 UTC	PENSKE AUTOMOTIVE GROUP, INC. PAG · Entity 1680	SaleCommon Stock	226,603	$44.13	$9,999,990.39	Disclosure SEC source: 0001209191-18-021764 · doc4.xml · nonDerivative · entry 2 MITSUI & CO LTD · CIK 0000067099 · 10% owner MITSUI & CO USA INC · CIK 0001283674 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,664,042 F1 · kind: Shares sold pursuant to the Purchase Agreement, by and between the Reporting Persons and Penske Automotive Group, Inc., dated March 27, 2018. F2 · ownership.direct: These shares are owned of record and beneficially by Mitsui & Co. (U.S.A.), Inc., a wholly owned subsidiary of Mitsui & Co., Ltd. Read SEC document
March 27, 2018 Filed Mar 27, 2018 21:05 UTC	PENSKE AUTOMOTIVE GROUP, INC. PAG · Entity 1680	SaleCommon Stock	906,413	$44.13	$40,000,005.69	Disclosure SEC source: 0001209191-18-021764 · doc4.xml · nonDerivative · entry 1 MITSUI & CO LTD · CIK 0000067099 · 10% owner MITSUI & CO USA INC · CIK 0001283674 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,658,163 F1 · kind: Shares sold pursuant to the Purchase Agreement, by and between the Reporting Persons and Penske Automotive Group, Inc., dated March 27, 2018. Read SEC document
October 20, 2017 Filed Oct 23, 2017 20:32 UTC	PENSKE AUTOMOTIVE GROUP, INC. PAG · Entity 1680	SaleCommon Stock	220,799	$45.29	$9,999,986.71	Disclosure SEC source: 0001209191-17-057751 · doc4.xml · nonDerivative · entry 2 MITSUI & CO LTD · CIK 0000067099 · 10% owner MITSUI & CO USA INC · CIK 0001283674 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,890,645 F1 · kind: Shares sold pursuant to the Purchase Agreement, by and between the Reporting Persons and Penske Automotive Holdings Corp., dated October 20, 2017. F2 · ownership.direct: These shares are owned of record and beneficially by Mitsui & Co. (U.S.A.), Inc., a wholly owned subsidiary of Mitsui & Co., Ltd. Read SEC document
October 20, 2017 Filed Oct 23, 2017 20:32 UTC	PENSKE AUTOMOTIVE GROUP, INC. PAG · Entity 1680	SaleCommon Stock	883,197	$45.29	$39,999,992.13	Disclosure SEC source: 0001209191-17-057751 · doc4.xml · nonDerivative · entry 1 MITSUI & CO LTD · CIK 0000067099 · 10% owner MITSUI & CO USA INC · CIK 0001283674 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,564,576 F1 · kind: Shares sold pursuant to the Purchase Agreement, by and between the Reporting Persons and Penske Automotive Holdings Corp., dated October 20, 2017. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.